Screening compound: InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2

Screening compound: InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2
Screening compound: InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S428-0022

Molecular Formula

C19H23N3O3 (C19 H23 N3 O3)

Compound Name

1-benzoyl-4-[3-(oxan-4-yl)-1,2,4-oxadiazol-5-yl]piperidine

IUPAC name

1-benzoyl-4-[3-(oxan-4-yl)-124-oxadiazol-5-yl]piperidine

SMILES

O=C(c1ccccc1)N(CC1)CCC1c1nc(C2CCOCC2)no1

InChI

InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2

InChI Key

QWOWSJMZLZYYRT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD29007470

InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2 in Drug Discovery

Included in Screening Libraries

Bcl2-PPI Inhibitors Library (12246 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

Lipid Metabolism Library (9174 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Hemic and lymphatic
  • Nervous system
  • Eye
  • Cardiovascular
  • Metabolic
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • Ion Channels
Structure:
  • Cyclic compounds

References: we are preparing a list of scientific research reports with InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2?
Check Price and Availability of InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C19H23N3O3/c23-19(16-4-2-1-3-5-16)22-10-6-15(7-11-22)18-20-17(21-25-18)14-8-12-24-13-9-14/h1-5,14-15H,6-13H2 available by request